Greatmark Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.8M Buy
71,294
+271
+0.4% +$92.8K 2.85% 10
2026
Q1
$25M Buy
71,023
+272
+0.4% +$97K 2.93% 11
2025
Q4
$23.2M Sell
70,751
-1,552
-2% -$492K 2.74% 11
2025
Q3
$20.4M Buy
72,303
+58
+0.1% +$16.8K 2.45% 15
2025
Q2
$20.2M Buy
72,245
+1,608
+2% +$456K 2.53% 14
2025
Q1
$22M Buy
70,637
+1,821
+3% +$538K 3% 10
2024
Q4
$17.9M Buy
68,816
+3,743
+6% +$1.11M 2.44% 14
2024
Q3
$21M Buy
65,073
+1
+0% +$327 2.84% 11
2024
Q2
$20.3M Buy
65,072
+518
+0.8% +$152K 2.97% 9
2024
Q1
$18.4M Buy
64,554
+2,045
+3% +$598K 2.61% 13
2023
Q4
$18M Buy
62,509
+205
+0.3% +$55.9K 2.82% 10
2023
Q3
$16.7M Sell
62,304
-1,496
-2% -$373K 2.96% 8
2023
Q2
$14.2M Buy
63,800
+2,957
+5% +$686K 2.38% 16
2023
Q1
$14.7M Sell
60,843
-1,971
-3% -$484K 2.62% 13
2022
Q4
$16.5M Sell
62,814
-973
-2% -$261K 3.02% 10
2022
Q3
$14.4M Buy
63,787
+1,055
+2% +$256K 2.78% 13
2022
Q2
$15.3M Buy
62,732
+52
+0.1% +$12.7K 2.93% 12
2022
Q1
$15.2M Buy
62,680
+4,635
+8% +$1.06M 2.49% 14
2021
Q4
$13.1M Buy
58,045
+13,402
+30% +$2.83M 2.19% 18
2021
Q3
$9.49M Buy
44,643
+7,216
+19% +$1.66M 1.78% 21
2021
Q2
$9.12M Buy
37,427
+22,341
+148% +$5.5M 1.65% 23
2021
Q1
$3.75M Buy
15,086
+1,527
+11% +$364K 0.73% 32
2020
Q4
$3.12M Buy
13,559
+6,201
+84% +$1.43M 0.67% 36
2020
Q3
$1.87M Buy
7,358
+140
+2% +$34.7K 0.47% 43
2020
Q2
$1.7M Buy
7,218
+155
+2% +$35.4K 0.45% 45
2020
Q1
$1.43M Buy
7,063
+580
+9% +$127K 0.46% 45
2019
Q4
$1.56M Buy
6,483
+1,410
+28% +$311K 0.39% 50
2019
Q3
$982K Buy
5,073
+2,300
+83% +$441K 0.27% 60
2019
Q2
$511K Buy
2,773
+760
+38% +$136K 0.15% 72
2019
Q1
$382K Hold
2,013
0.12% 85
2018
Q4
$392K Buy
2,013
+750
+59% +$146K 0.14% 79
2018
Q3
$262K Hold
1,263
0.08% 104
2018
Q2
$233K Hold
1,263
0.08% 101
2018
Q1
$215K Hold
1,263
0.08% 105
2017
Q4
$220K Sell
1,263
-57
-4% -$10.1K 0.08% 102
2017
Q3
$246K Hold
1,320
0.09% 97
2017
Q2
$227K Hold
1,320
0.09% 96
2017
Q1
$217K Buy
+1,320
New +$219K 0.09% 93
2016
Q4
Sell
-1,320
Closed -$220K 99
2016
Q3
$220K Hold
1,320
0.1% 85
2016
Q2
$201K Buy
+1,320
New +$205K 0.09% 88
2016
Q1
Sell
-1,320
Closed -$214K 88
2015
Q4
$214K Buy
+1,320
New +$207K 0.09% 81
2015
Q3
Sell
-1,320
Closed -$203K 85
2015
Q2
$203K Hold
1,320
0.09% 83
2015
Q1
$211K Hold
1,320
0.09% 87
2014
Q4
$210K Buy
+1,320
New +$206K 0.09% 86

Other funds holding AMGN

Greatmark Investment Partners's AMGN Position: Q2 2026 in Review

Greatmark Investment Partners increased its Amgen (AMGN) stake by 0.38% in Q2 2026, buying an estimated $92.8K and bringing the position to 71,294 shares worth $25.8M. The position accounts for 2.85% of the portfolio, ranked #10.

Greatmark Investment Partners first reported a position in AMGN in Q4 2014 and has held it in 44 quarters since. 1,224 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Greatmark Investment Partners held 71,294 shares of Amgen worth $25.8M as of Q2 2026.
  • Greatmark Investment Partners bought 271 Amgen shares in Q2 2026, an estimated $92.8K.
  • Amgen made up 2.85% of Greatmark Investment Partners's portfolio in Q2 2026, its #10 holding.
  • Greatmark Investment Partners first reported a position in Amgen in Q4 2014 and has held it in 44 quarters since.
  • 1,224 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Greatmark Investment Partners's 13F filing for Q2 2026, filed 24 Jul 2026.